이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Postoperative Pacing for Cardiac Efficiency (POSTPACE)

2026년 9월 30일 업데이트: Robert G. Webster, MD, MPH

The goal of this study is to determine whether temporarily increasing a child's heart rate after heart surgery can improve blood flow and oxygen supply to the body's tissues. The study will compare temporary atrial pacing at 10 and 20 beats per minute above the child's natural heart rate with the child's natural heart rate without pacing.

Participants will be randomly assigned to one of two schedules for these pacing approaches. Each pacing approach has previously been used as part of routine care after heart surgery. The study will test whether temporarily increasing the heart rate improves blood flow and oxygen supply during the first 10 hours after surgery.

연구 개요

상세 설명

This study uses a randomized, within-subject design to evaluate three postoperative heart rate conditions: intrinsic sinus rhythm, temporary atrial pacing at 10 beats per minute above the intrinsic sinus rate, and temporary atrial pacing at 20 beats per minute above the intrinsic sinus rate. Participants will be randomized to one of two sequences determining the order in which these conditions are administered. Each pacing condition will be maintained for approximately three hours during the early postoperative period.

Participants will be grouped according to single-ventricle or two-ventricle physiology. The study uses a within-subject design so that each participant serves as their own control when comparing physiologic responses to the three heart rate conditions.

Continuous physiologic data will be collected during the postoperative study period using the institutional Sickbay physiologic data acquisition platform. Data obtained through routine postoperative monitoring will be used to characterize physiologic responses during and between pacing conditions. No additional physiologic monitoring devices or research-only laboratory testing are required.

A secondary component of the study evaluates the electrophysiologic properties of temporary epicardial pacing wires during the postoperative period. We will measure how much electricity is required to pace the heart on the first day after surgery and daily through postoperative day 3. Threshold testing is performed using standard clinical pacing equipment and techniques and only when the treating clinical team determines that testing is clinically appropriate and safe.

The study is open-label; neither treating clinicians nor study personnel are blinded to pacing status or pacing rate. Study-specific procedures are limited to the postoperative hospitalization, with data collection continuing through the 3-day postoperative period. After completion or discontinuation of protocol-directed pacing, subsequent pacing and medical management are determined solely by the treating clinical team.

연구 유형

중재적

등록 (추정된)

46

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

    • Illinois
      • Chicago, Illinois, 미국, 60611
        • 모병
        • Ann & Robert H. Lurie Children's Hospital of Chicago
        • 연락하다:
        • 연락하다:
        • 수석 연구원:
          • Robert G Webster, MD, MPH

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

12년 이하 (어린이)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Age less than 12 years (all potential recruitment). Target recruitment will focus on children less than 12 months at enrollment. Children aged 13-36 months will be eligible for recruitment if we do not meet the target recruitment goals for infants according to the study timeline, and then all patients < 12 years if recruitment is still below targets.
  • Scheduled for congenital cardiac surgery at Lurie Children's Hospital
  • Planned postoperative admission to the CICU
  • Informed consent obtained from parent(s) or legally authorized representative(s)

Exclusion Criteria:

  • Pregnant patient at time of surgery
  • Category 2 and category 3 patients on the pulmonary artery reconstruction (PAR) program
  • Junctional or ventricular rhythm at baseline
  • Uncontrolled tachyarrhythmia (for example, but not limited to, atrial or ventricular tachycardia, atrioventricular re-entrant arrhythmias)
  • Hemodynamically significant bleeding, defined as active bleeding that, in the judgment of the treating clinical team, requires ongoing blood product transfusion, surgical or catheter-based intervention, or results in hemodynamic instability requiring escalation of clinical support
  • Postoperative cardiac arrest prior to protocol initiation or during the protocol period
  • Requirement for mechanical circulatory support
  • Requirement for ventricular pacing
  • Arterial pH less than 7.10
  • Determination by the treating clinical team that participation is not in the patient's best clinical interest

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 크로스오버 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Group 1: No pacing, +20 bpm, +10 bpm

Participants first undergo intrinsic sinus rhythm without protocol-directed atrial pacing, followed by temporary atrial pacing at 20 beats per minute above the intrinsic sinus rate and then 10 beats per minute above the intrinsic sinus rate. Each condition is maintained for approximately three hours.

Temporary atrial pacing is delivered using temporary epicardial atrial pacing wires placed during cardiac surgery. During the protocol-directed pacing period, participants receive atrial pacing at either 10 or 20 beats per minute above their intrinsic sinus heart rate, according to their randomly assigned sequence. Each pacing condition is maintained for approximately three hours. The comparison condition is intrinsic sinus rhythm without protocol-directed atrial pacing. The protocol-directed pacing period occurs during approximately the first 10 postoperative hours. Pacing may be temporarily interrupted, skipped, or discontinued at the discretion of the treating clinical team when clinically indicated.

실험적: Group 2: +20 bpm, +10 bpm, no pacing

Participants first undergo temporary atrial pacing at 20 beats per minute above the intrinsic sinus rate, followed by atrial pacing at 10 beats per minute above the intrinsic sinus rate and then intrinsic sinus rhythm without protocol-directed atrial pacing. Each condition is maintained for approximately three hours.

Temporary atrial pacing is delivered using temporary epicardial atrial pacing wires placed during cardiac surgery. During the protocol-directed pacing period, participants receive atrial pacing at either 10 or 20 beats per minute above their intrinsic sinus heart rate, according to their randomly assigned sequence. Each pacing condition is maintained for approximately three hours. The comparison condition is intrinsic sinus rhythm without protocol-directed atrial pacing. The protocol-directed pacing period occurs during approximately the first 10 postoperative hours. Pacing may be temporarily interrupted, skipped, or discontinued at the discretion of the treating clinical team when clinically indicated.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Change in Mean Renal Near-Infrared Spectroscopy (NIRS) Across Three Pacing Conditions
기간: The time frame for the mean renal NIRS will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.

Renal near-infrared spectroscopy (NIRS) is a noninvasive monitor that estimates the amount of oxygen in blood within the tissues of the kidney. Renal NIRS will be continuously measured during each of the three study conditions: intrinsic sinus rhythm without protocol-directed pacing, atrial pacing at 10 beats per minute above the intrinsic sinus rate, and atrial pacing at 20 beats per minute above the intrinsic sinus rate. The mean renal NIRS value during the final 30 minutes of each approximately 3-hour condition will be used for analysis. The primary outcome will assess the change in mean renal NIRS across the three pacing conditions, with each participant serving as their own control. Expected values for renal NIRS in post-operative cardiac surgery patients with congenital heart disease range from 45% to > 95%.

The time frame for the mean renal NIRS will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.

2차 결과 측정

결과 측정
측정값 설명
기간
Change in Cerebral NIRS Across Three Pacing Conditions
기간: The time frame for the cerebral NIRS will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.

Cerebral near-infrared spectroscopy (NIRS) is a noninvasive monitor that estimates the amount of oxygen in blood within brain tissue. Cerebral NIRS will be measured during the three study conditions: intrinsic sinus rhythm without protocol-directed pacing, atrial pacing at 10 beats per minute above the intrinsic sinus rate, and atrial pacing at 20 beats per minute above the intrinsic sinus rate. Expected values for cerebral NIRS in post-operative cardiac surgery patients with congenital heart disease range from 45% to > 95%.

The time frame for the cerebral NIRS will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.
Change Mean Arterial Pressure Across Three Pacing Conditions
기간: The time frame for the mean arterial pressure will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.

Mean arterial pressure is an estimate of the average pressure in the arteries during a heartbeat and is routinely monitored after cardiac surgery. Mean arterial pressure will be recorded during the three study conditions. The mean value during the final 30 minutes of each approximately 3-hour condition will be compared across intrinsic sinus rhythm, atrial pacing at 10 beats per minute above the intrinsic sinus rate, and atrial pacing at 20 beats per minute above the intrinsic sinus rate. Expected ranges vary by age, sex and height (e.g., PMID: 28827377) and are adjusted for post-surgical status as opposed to ambulatory screening and management.

The time frame for the mean arterial pressure will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.
Change in Mean Arterial Oxygen Saturation Across Three Pacing Conditions
기간: The time frame for the mean arterial pressure will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.

Arterial oxygen saturation is the percentage of hemoglobin in the blood that is carrying oxygen. It will be monitored during the three study conditions. The mean arterial oxygen saturation during the final 30 minutes of each approximately 3-hour condition will be compared across intrinsic sinus rhythm, atrial pacing at 10 beats per minute above the intrinsic sinus rate, and atrial pacing at 20 beats per minute above the intrinsic sinus rate. Expected values for mean arterial oxygen saturation in post-operative cardiac surgery patients with congenital heart disease range from 60% to > 95%.

The time frame for the mean arterial pressure will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.
Change in Central Venous Pressure Across Three Pacing Conditions
기간: The time frame for the mean central venous pressure will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.

Central venous pressure is the pressure measured in the central veins returning blood to the heart. Central venous pressure will be monitored as part of routine postoperative care. The mean central venous pressure during the final 30 minutes of each approximately 3-hour condition will be compared across intrinsic sinus rhythm, atrial pacing at 10 beats per minute above the intrinsic sinus rate, and atrial pacing at 20 beats per minute above the intrinsic sinus rate. Central venous pressure is highly dependent on the type of congenital heart disease repaired and will be compared to patients with similar physiology. Across a range of physiologic states, values are typically between 3 mmHg and 25 mmHg.

The time frame for the mean central venous pressure will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.
Change in Mean Airway Pressure Across Three Pacing Conditions
기간: The time frame for the mean airway pressure will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.

Mean airway pressure is the average pressure in the airways during a respiratory cycle. It will be recorded when available as part of routine postoperative care. The mean airway pressure during the final 30 minutes of each approximately 3-hour condition will be compared across intrinsic sinus rhythm, atrial pacing at 10 beats per minute above the intrinsic sinus rate, and atrial pacing at 20 beats per minute above the intrinsic sinus rate. Normal values are between 5-10 cmH₂O for our participant population.

The time frame for the mean airway pressure will be during the final 30 minutes of each of the approximately 3-hour pacing conditions.
Change in Serum Lactate Concentration During the First 72 Hours After Surgery
기간: The time frame for the serum lactate concentration will be from initiation of the baseline observation period through 72 hours after CICU admission.

Serum lactate concentration will be obtained from laboratory testing performed as part of routine postoperative clinical care. Lactate values and their corresponding collection times will be recorded and used to evaluate changes in lactate concentration following surgery and in relation to the study pacing conditions. No additional blood samples are required for the study. Expected values are lower than 10 mmol/L for most patients during recovery, although higher values are possible during marginal physiologic states. There is no meaningful interpretation of a low lactate level during surgical recovery and a level below the threshold of assay detection will be interpreted as a normal value.

The time frame for the serum lactate concentration will be from initiation of the baseline observation period through 72 hours after CICU admission.
Change in Arterial pH During the First 72 Hours After Surgery
기간: The time frame for the arterial pH will be from initiation of the baseline observation period through 72 hours after CICU admission.

Arterial pH measures the acidity or alkalinity of arterial blood. Arterial pH values obtained from blood gas testing performed as part of routine postoperative clinical care will be recorded with their corresponding collection times. Changes in arterial pH will be evaluated during the postoperative period in relation to the study pacing conditions. No additional blood samples are required for the study. While physiologic values between 7.35 and 7.45 are target values, we anticipate that patients will transiently have values between 7.2 and 7.35. Values lower than 7.2 will be evaluated by our clinical team. It is unusual to have significant non-iatrogenic alkalosis in the post-surgical state.

The time frame for the arterial pH will be from initiation of the baseline observation period through 72 hours after CICU admission.
Change in Arterial Bicarbonate Concentration During the First 72 Hours After Surgery
기간: The time frame for the arterial bicarbonate concentration will be from initiation of the baseline observation period through 72 hours after CICU admission.

Arterial bicarbonate concentration is a measure obtained from arterial blood gas testing that provides information about the body's acid-base balance. Bicarbonate values obtained as part of routine postoperative clinical care will be recorded with their corresponding collection times. Changes in arterial bicarbonate concentration will be evaluated during the postoperative period in relation to the study pacing conditions. No additional blood samples are required for the study. We expected values between 21-27 mmol/L for our participant population.

The time frame for the arterial bicarbonate concentration will be from initiation of the baseline observation period through 72 hours after CICU admission.
Change in Intrinsic Heart Rate Across Three Pacing Conditions
기간: The time frame for the intrinsic heart rate will be during the final 15 minutes of each approximately 3-hour pacing conditions.

Intrinsic heart rate is the participant's natural heart rate without protocol-directed atrial pacing. Heart rate will be continuously monitored during each study condition. Intrinsic heart rate measurements will be used to characterize the participant's underlying heart rate during the pacing phases and to evaluate changes associated with the different pacing conditions. Normal values are between 100-180 bpm for our participant population.

The time frame for the intrinsic heart rate will be during the final 15 minutes of each approximately 3-hour pacing conditions.
Pacing Capture Thresholds and Derived Rheobase and Chronaxie During the First 72 Hours After Surgery
기간: The time line will be at baseline and postoperative days 1, 2, and 3.

Pacing capture thresholds are the minimum electrical stimulus strengths required to consistently capture the heart and will be measured across multiple pulse durations using temporary epicardial pacing wires and routine temporary pacing equipment. These measurements will be used to construct postoperative strength-duration curves and derive rheobase and chronaxie, which describe the electrical stimulus characteristics required for cardiac capture. Measurements will be obtained at baseline and daily through postoperative day 3 to evaluate changes in pacing requirements and electrophysiologic properties over the postoperative period.

The time line will be at baseline and postoperative days 1, 2, and 3.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Robert G Webster, MD, MPH, Ann & Robert H Lurie Children's Hospital of Chicago

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

일반 간행물

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 10월 1일

기본 완료 (추정된)

2027년 12월 31일

연구 완료 (추정된)

2027년 12월 31일

연구 등록 날짜

최초 제출

2026년 9월 24일

QC 기준을 충족하는 최초 제출

2026년 9월 30일

처음 게시됨 (실제)

2026년 10월 1일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 10월 1일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 30일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

We are happy to provide aggregate data, but with N<50 and complex congenital heart disease (which tends to be highly unique in description), providing individual-level data from a single-center study is a potential risk for re-identification.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다